Chris L. PASHOS

Dr. Pashos focuses on improving patient health care and outcomes. He has demonstrated leadership in academia, consulting, and global life sciences companies, primarily using real-world evidence (RWE), patient-centered research (PCR), and other aspects of health economics and outcomes research (HEOR).

Currently he serves on the Board of Directors of Genesis Research, an international RWE and HEOR consultancy supporting the life sciences industry.  He is also on the Board of Advisors of OtisHealth, a digital health platform connecting patients with clinicians, and supporting both better health of individual patients and research contributing to improved population health.

Previously, he served as Vice President, Global Evidence Strategy at AbbVie, strengthening collaboration among global, regional and country-level organizations.  Before that, also as Vice President, he led Takeda’s Global Outcomes and Epidemiology Research, delivering critical insights from early development through the life cycle, integrated across R&D, Medical and Commercial units, working collaboratively worldwide.

Dr. Pashos began his health research career at Harvard Medical School, where he managed the acute myocardial infarction Patient Outcomes Research Team (PORT), one of the first PORTs funded by the United States government to improve healthcare quality.  He also helped create and direct the Harvard Bridges Program, which brought together policymakers, academic experts, and business decision makers to identify possible solutions to critical health care issues. After leaving the Harvard faculty in 1995, he founded and led a consultancy at Abt Associates whose clients were most of the world’s leading life sciences companies.

Having lived in North America and Europe and worked around the world, Dr. Pashos had worked in numerous therapeutic areas, notably oncology, hematology, cardio-metabolic diseases, neuroscience, urology, rare diseases, and women's health. His research has appeared in more than 125 medical journal publications; more than 300 presentations and reports; and input to UNICEF, NIH, and policy makers worldwide.

A Charter Member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Dr. Pashos served as ISPOR President in 2008-2009.  A recipient of the ISPOR Distinguished Service Award, he led the development of and served as co-editor of Health Care Costs, Quality and Outcomes: ISPOR Book of Terms (which has been translated from English into many other languages), and the ISPOR LEXICON, the original official dictionary of the Society.